BREAST CANCER INVASIVE
Clinical trials for BREAST CANCER INVASIVE explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER INVASIVE trials appear
Sign up with your email to follow new studies for BREAST CANCER INVASIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study explores combining breast removal, reconstruction, and radiation in one treatment plan
Disease control CompletedThis study looked at a treatment plan for women with invasive breast cancer that involves removing the breast (mastectomy) and immediately rebuilding it with an implant, followed by radiation therapy (sometimes with chemotherapy). The goal was to see how often this approach works…
Matched conditions: BREAST CANCER INVASIVE
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated May 26, 2026 06:00 UTC
-
New scanner could slash repeat breast cancer surgeries
Diagnosis CompletedThis study tested whether a high-resolution PET-CT scan of the removed tumor during breast-conserving surgery can help surgeons see if any cancer cells are left behind. About 206 women with early-stage breast cancer received a low-dose radioactive tracer before surgery. After the…
Matched conditions: BREAST CANCER INVASIVE
Phase: NA • Sponsor: XEOS Medical • Aim: Diagnosis
Last updated May 26, 2026 06:07 UTC
-
New scan could spot breast cancer spread without surgery
Diagnosis CompletedThis study tested whether a special PET scan called FES PET/CT can accurately detect breast cancer that has spread to lymph nodes under the arm. It involved 71 adults with estrogen-positive breast cancer who were suspected of having lymph node involvement. The goal was to see if …
Matched conditions: BREAST CANCER INVASIVE
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated May 26, 2026 04:37 UTC
-
Baby tamoxifen shows lasting protection against breast cancer in High-Risk women
Prevention CompletedThis study looks at the long-term effects of taking a low dose of tamoxifen (5 mg daily for 3 years) to prevent breast cancer from coming back in women who had early-stage breast changes or very small tumors. Researchers will follow about 1,500 women for many years to see how wel…
Matched conditions: BREAST CANCER INVASIVE
Sponsor: Ente Ospedaliero Ospedali Galliera • Aim: Prevention
Last updated May 22, 2026 14:03 UTC